Health consequences of overweight and obesity in adults

Obesity Epidemiology: From Aetiology to Public Health

Volumn , Issue , 2010, Pages

  Lean, Michael ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Epidemiology; Health consequences; Health impact; Obese adults; Obesity epidemic; Public health

Indexed keywords

EID: 84921258619     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780199571512.003.0004     Document Type: Chapter

References (35)

1. Unicef Humanitarian Action Report 2008
2. Lean MEJ, Han TS, Deurenberg P (1996). Predicting body composition by densitometry from simple anthropometric measurements. Am J Clin Nutr, 63, 4-14.
3. Pischon T and Sharma AM (2001). Use of beta-blockers in obesity hypertension: potential role of weight gain. Obes Rev, 2(4), 275-280.
4. Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995). Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med, 122(7), 481-486.
5. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994). Obesity, fat distribution and weight gain, as risk factors for clinical diabetes in men. Diabs Care, 17(9), 961-969.
6. UK Prospective Diabetes Study (UKPDS) VIII. (1991). Study, design, progress and performance. Diabetologia, 34(12), 877-890.
7. Lean MEJ, Powrie JK, Anderson AS, Garthwaite PH (1990). Obesity, weight loss and prognosis in type 2 diabetes. Diab Med, 7, 228-233.
8. Hillier TA and Pedula KL (2001). Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabs Care, 24, 1522-1527.
9. Lean MEJ, Han TS, Morrison EC (1995). Waist circumference as a measure for indicating need for weight management. BMJ, 311, 158-161.
10. World Health Organization WHO (1998). Obesity: Preventing and managing the global epidemic. Geneva.
11. Hughes D, McGuire A, Elliot H, et al. (1999). The cost of obesity in the United Kingdom. J Med Econ, 2, 143-153.
12. Von Behren J, Lipsett M, Horn-Ross PL, et al. (2009). Obesity, waist size and prevalence of current asthma in the California Teachers Study cohort. Thorax, 64(10), 889-893.
13. McLachlan CR, Poulton R, Car G, et al. (2007). Adiposity, asthma and airway inflammation. J Allergy Clin Immunol, 119(3), 634-639.
14. Lew EA and Garfinkel L (1979). Variations in mortality by weight among 750,000 men and women. J Chronic Dis, 32(8), 563-576.
15. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 2001, 285, 2486-97.
16. Isomaa B, Almgren P, Tuomi T, et al. (2001). Cardiovascular morbidity and mortality associated with the Metabolic Syndrome. Diabetes Care, 24(4), 683-689.
17. Echouffo-Tcheugui JB, Sargeant LA, Prevost AT, et al. (2008). How much might cardiovascular disease risk be reduced by intensive therapy in people with screendetected diabetes? Diabet Med, 25(12), 1433-1439.
18. Tuomilehto J, Lindstom J, Eriksson JG, et al. (2001). Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med, 344(18), 1343-1350.
19. Knowler WC, Barrett-Connor E, Fowler SE, et al. (2002). Diabetes Prevention Programme Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 346(6), 393-403.
20. Dixon JB, O'Brien PE, Playfair J, et al. (2008). Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA, 23, 316-323.
21. World Cancer Research Fund. (2007). Food, nutrition, physical activity and the prevention of cancer: a global perspective.
22. World Health Organization. (2003). Diet, nutrition and the prevention of chronic diseases. WHO Technical Report Series 916, Geneva.
23. Weinsier RL and Ullmann DO (1993). Gallstone formation and weight loss. Obes Res, 1(1), 51-56.
24. Hagen KB, Byfuglien MG, Falzone L, Olsen SU, Smedslund G (2009). Diet interventions for rheumatoid arthritis. Cochrane Database Syst Rev, Jan 21, CD006400.
25. Chapman-Kiddell CA, Davies PSW, Gillen L, Radford-Smith GL (2010). Role of diet in the development of inflammatory bowel disease. Inflam Bowel Diseases, 16(1) 137-151.
26. Anandacoomarasamy A, Caterson I, Sambrook P, Fransen M, March L (2008). The impact of obesity on the musculoskeletal system. Int J Obes, 32, 211-222.
27. The Counterweight Project Team (2005). The impact of obesity on drug prescribing in primary care. Br J Gen Pract, 55, 743-749.
28. Leslie WS, Hankey CR, Lean ME (2007). Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review. Quarterly J Med, 100(7), 395-404.
29. Sullivan M, Karlsson J, Sjöström L, et al. (1993). Swedish obese subjects (SOS)- an intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined. Int J Obes, 19(9), 503-512.
30. Kraja AT, Rao DC, Weder A, et al. (2005). An evaluation of the metabolic syndrome in a large multi-ethnic study: the Family Blood Pressure Program. Nutr Metab, 2, 17.
31. Hanefeld M, Koehler C, Gallo S, Benke I, Ott P (2007). Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardio Diabetology, 6, 13.
32. SIGN No 8. Obesity in Scotland: integrating prevention with weight management 1996. Scottish Intercollegiate Guideline Network. Edinburgh.
33. Goldstein DJ (1992). Beneficial health effects of modest weight loss. Int J Obes, 16, 397-415.
34. Torgerson JS and Sjöström L (2001). The Swedish Obese Subjects (SOS) study -rationale and results. Int J Obes, 25(S1), S2-4.
35. Sjöström CD, Peltonen M, Wedel H, Sjöström L (2000). Differentiated longterm effects of intentional weight loss on diabetes and hypertension. Hypertension, 36(1), 20-25.